BEUDAMED
    12 results · 8ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 2 ×

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·IMMULITE PSA CATALOG # LKPS1,5)

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·IMMULITE(R) THIRD GENERATION PSA

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·IMMULITE(R)PSA, IMMULITE(R) THIRD GENERATION PSA, IMMULITE(R) 2000

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·IMMULITE/IMMULITE 1000 PSA & 1000 THIRD GENERATION PSA

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA Pre-Market Approval
    FDA Class 2 ·IMMULITE 2500 PSA, IMMULITE 2500 THIRD GENERATION PSA

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·ARTUS CMV RGQ MDX KIT

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·Artus CMV RGQ and QS-RGQ MDx Kit

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·artus CMV RGQ MDx Kit and artus CMV QS_RGQ MDx Kit

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·ARTUS CMV RGQ MDX KIT

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·ARTUS CMV RGQ MDX KIT

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·artus CMV RGQ MDx Kit and artus CMV QS-RGO MDx Kit

    Cytomegalovirus (Cmv) Dna Quantitative Assay

    FDA Pre-Market Approval
    FDA Class 2 ·artus CMV RGQ MDx Kit and artus CMV QS-RGQ MDx Kit